A detailed history of Advisor Net Financial, Inc transactions in Novo Cure LTD stock. As of the latest transaction made, Advisor Net Financial, Inc holds 8,966 shares of NVCR stock, worth $153,228. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,966
Previous 8,000 12.08%
Holding current value
$153,228
Previous $137,000 2.19%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$15.61 - $23.34 $15,079 - $22,546
966 Added 12.08%
8,966 $140,000
Q2 2024

Jul 16, 2024

BUY
$11.83 - $24.05 $29,575 - $60,125
2,500 Added 45.45%
8,000 $137,000
Q1 2024

Apr 12, 2024

BUY
$12.42 - $17.29 $31,050 - $43,225
2,500 Added 83.33%
5,500 $85,000
Q2 2023

Jul 14, 2023

BUY
$40.29 - $82.51 $32,232 - $66,008
800 Added 36.36%
3,000 $124,000
Q1 2023

Apr 28, 2023

SELL
$56.44 - $118.81 $564 - $1,188
-10 Reduced 0.45%
2,200 $132,000
Q4 2022

Jan 13, 2023

BUY
$63.98 - $85.37 $25,592 - $34,148
400 Added 22.1%
2,210 $0
Q2 2022

Jul 07, 2022

BUY
$56.6 - $89.9 $566 - $899
10 Added 0.56%
1,810 $126,000
Q1 2022

Apr 14, 2022

SELL
$60.15 - $84.52 $300 - $422
-5 Reduced 0.28%
1,800 $149,000
Q4 2021

Jan 19, 2022

BUY
$75.08 - $121.99 $36,338 - $59,043
484 Added 36.64%
1,805 $136,000
Q4 2020

Feb 04, 2021

BUY
$112.16 - $174.14 $672 - $1,044
6 Added 0.46%
1,321 $229,000
Q2 2020

Aug 26, 2020

BUY
$57.2 - $74.41 $71,500 - $93,012
1,250 Added 1923.08%
1,315 $78,000
Q4 2019

Feb 12, 2020

BUY
$68.3 - $93.8 $4,439 - $6,097
65 New
65 $5,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.79B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.